QA: Mirati Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2020_Mirati_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc

  xvar xval
0 AssetsCurrent 424,407,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,776,000
3 remainder_Assets 6,017,000
4 LiabilitiesCurrent 48,906,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 999,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 110,576,560
9 ResearchAndDevelopmentExpense 626,293,882
10 remainder_Expenses 0
11 remainder_Revenues 8,339,026
12 remainder_NetIncome 32,006,764
13 remainder_ComprehensiveNetIncome 2,453,643
  yvar yval
0 Assets 432,200,000
1 Liabilities 49,905,000
2 Expenses 736,870,442
3 Revenues 8,339,026
4 StockholdersEquity 382,295,000
5 NetIncome -696,524,652
6 ComprehensiveNetIncome -695,297,830
7 BaseVar 630,887,438
8 EconomicCapitalRatiobeforeLimitedLiability 0.573
9 EconomicCapitalRatio 1.95

Edgar->Model Mapping

Feature Distribution

Change over Time